跳至主要内容
临床试验/NL-OMON56976
NL-OMON56976尚未招募不适用

Sentinel node and organ sparing surgery in stage I colon carcinoma (SENTRY trial) - SENTRY

Meander Medisch Centrum0 个研究点目标入组 325 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
325

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Oral and written informed consent (IC)
  • - Aged 18 years and older
  • - Fit for both organ-sparing surgery and colectomy
  • - Pathologically confirmed high-risk T1 or low-risk T2 adenocarcinoma of the
  • colon after R0/R1/Rx endoscopic resection
  • - The resection scar after local excision is expected to be clearly recognized
  • at endoscopy, either by a tattoo or by detecting a scar in the colorectal
  • segment where no other polypectomies were performed
  • High-risk features for T1-T2 colorectal carcinoma are:
  • - Poor differentiation grade or undifferentiated (WHO classification of
  • tumours: exhibits glandular structures in <50%)
  • - Positive tumour budding (tumour budding grade 2-3)
  • - Presence of lymphovascular invasion (The presence of cancer cells within
  • endothelial-lined channels)

排除标准

  • - Lesion located <25cm from the anus based on endoscopic measurement
  • - Distant metastasis
  • - Mucinous or signet ring cell carcinoma
  • - Lynch syndrome
  • - Other primary malignancy treated within 5 years prior to diagnosis of colon
  • cancer, except for curatively treated prostate, breast, skin and cervical cancer
  • - Tumours that comprised >50% of the colon circumference before endoscopic
  • - Tumours involving the ileocaecal valve
  • - Pregnancy, lactation or a planned pregnancy during the course of the study
  • - Known allergy to any of the compounds used for SLN identification (ICG,
  • Iodine or Sodium iodide)
  • - Previous colonic surgery (excluding appendectomy).
  • - Contra-indication for laparoscopic or robotic surgery
  • - Severe kidney- or liver failure
  • - Hyperthyroidism or an autonomously functioning thyroid adenoma

研究者

发起方
Meander Medisch Centrum

相似试验